Oliver Eng, MD

Oliver Eng, MD
Title: Surgical Oncologist
Education: Brown University, Rutgers University
Expertise: Oncology
  • Board-certified surgical oncologist
  • Associate professor at the University of California, Irvine

Experience

Oliver Eng, MD, is a surgeon, surgical oncologist, and associate professor of surgery at the University of California, Irvine. His focus includes treating cancers in the abdomen, complex cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC). HIPEC is the process of delivering high-dose heated chemotherapy in the operating room after surgical removal of visible disease. HIPEC is effective in different types of cancers. Before teaching at UC Irvine, Dr. Eng led one of the most robust peritoneal surface malignancy programs in the country as an assistant professor of surgery at the University of Chicago. 


Dr. Eng has co-authored peer-reviewed manuscripts in journals including Cancer Discovery, Cancer, British Journal of Cancer, and JAMA Surgery. The research he completed on the molecular and immunologic characteristics of peritoneal tumors was funded by both extramural and intramural funding. The goal of his research was to develop innovative therapies for metastatic disease and optimize outcomes and care in cancer patients. Today, Dr. Eng serves on the editorial board for various scientific journals and national committees. 

Education

He graduated from Brown University and completed his general surgery residency at Rutgers University. Dr. Eng completed his fellowship in complex general surgical oncology at City of Hope National Medical Center.

About Health

Health.com, a Dotdash Meredith Brand, is an award-winning online resource for empathetic, trustworthy, and actionable health and wellness information so you can make the best choice for your health. We reach more than 9 million readers a month. We ensure the accuracy of our content by relying on seasoned health journalists, credentialed medical professionals and thorough fact checkers. Learn more about us and our editorial process.